A carregar...
NEW AND EMERGING DEVELOPMENTS IN EXTENSIVE STAGE SMALL CELL LUNG CANCER THERAPEUTICS
PURPOSE OF REVIEW: Extensive-stage small cell lung cancer (SCLC) remains a disease with a dismal prognosis, with median survival of approximately 8–10 months. Despite many attempts to develop effective systemic therapies, very little progress has been made in the last several decades. Platinum-based...
Na minha lista:
| Publicado no: | Curr Opin Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5139911/ https://ncbi.nlm.nih.gov/pubmed/26844984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0000000000000264 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|